Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Promising myeloma agents in phase II trials

Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical Center, New York, USA
Promising myeloma agents in phase II trials ( Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical Center, New York, USA )
2 Mar 2017

Ongoing transplant phase III trials for myeloma

Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Ongoing transplant phase III trials for myeloma ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017

Post autologous transplant therapies in high risk multiple myeloma: StaMINA trial update

Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Post autologous transplant therapies in high risk multiple myeloma: StaMINA trial update ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017

Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib for relapsed/refractory multiple myeloma

Dr David Siegel - John Theurer Cancer Center, Hackensack, USA
Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib for relapsed/refractory multiple myeloma ( Dr David Siegel - John Theurer Cancer Center, Hackensack, USA )
2 Mar 2017

Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma

Dr David Siegel - John Theurer Cancer Center, Hackensack, USA
Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma ( Dr David Siegel - John Theurer Cancer Center, Hackensack, USA )
2 Mar 2017

Examining strategies to tailor multiple myeloma immunotherapy

Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA
Examining strategies to tailor multiple myeloma immunotherapy ( Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA )
2 Mar 2017

Editor's Choice for February 2017

Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for February 2017 ( Prof Gordon McVie - Editor in Chief, ecancer )
24 Feb 2017

HPV vaccination priorities

Dr Nubia Muñoz - IARC, Lyon, France
HPV vaccination priorities ( Dr Nubia Muñoz - IARC, Lyon, France )
6 Jan 2017

Standardised tobacco packaging in the UK

Prof Ann McNeill - King's College London, London, UK
Standardised tobacco packaging in the UK ( Prof Ann McNeill - King's College London, London, UK )
5 Jan 2017

Ongoing education through the EAFO

Dr Somasundaram Subramanian - Eurasian Federation of Oncology (EAFO), Moscow, Russia
Ongoing education through the EAFO ( Dr Somasundaram Subramanian - Eurasian Federation of Oncology (EAFO), Moscow, Russia )
5 Jan 2017

Existing and prospective immunotherapeutics for biliary tract cancer

Prof Junji Furuse - Kyorin University Hospital Cancer Centre, Tokyo, Japan
Existing and prospective immunotherapeutics for biliary tract cancer ( Prof Junji Furuse - Kyorin University Hospital Cancer Centre, Tokyo, Japan )
3 Jan 2017

SBRT in prostate cancer

Dr Carlo Greco - Champalimaud Centre for the Unknown, Lisbon, Portugal
SBRT in prostate cancer ( Dr Carlo Greco - Champalimaud Centre for the Unknown, Lisbon, Portugal )
21 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation